(Q33613487)

28 July 2017

1 reference

title

Placebo, prozac and PLoS: significant lessons for psychopharmacology (English)

1 reference

28 July 2017

0 references

1 reference

Jamie Horder

1

0 references

author name string

Paul Matthews

series ordinal

2

1 reference

28 July 2017

Robert Waldmann

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

22 June 2010

1 reference

Journal of Psychopharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

25

1 reference

28 July 2017

issue

10

1 reference

28 July 2017

page(s)

1277-1288

1 reference

The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Is the antidepressive effect of second-generation antidepressants a myth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

21 January 2018

Ranking antidepressants.

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Clinical trials and the response rate illusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Comparative analysis of observer depression scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Publication bias and the efficacy of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Efficacy of antidepressants in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

The failure of placebo-controlled studies. ECNP Consensus Meeting, September 13, 1997, Vienna. European College of Neuropsychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

The good-subject effect: investigating participant demand characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Why does the world have such a 'down' on antidepressants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Efficacy of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

Placebo response in studies of major depression: variable, substantial, and growing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372544

21 January 2018

Identifiers

DOI

10.1177/0269881110372544

1 reference

release_snlktgg2x5hbvgw6td4frbi5hy

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/snlktgg2x5hbvgw6td4frbi5hy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference